International Clinical Trial: A real-world retrospective study evaluating the ADT combined with docetaxel and darolutamide triple therapy regimen for metastatic prostate cancer(YHCG-006)

Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118253) titled 'A real-world retrospective study evaluating the ADT combined with docetaxel and darolutamide triple therapy regimen for metastatic prostate cancer(YHCG-006)' on Feb. 3.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: The First Affiliated Hospital of Ningbo University

Condition: prostate cancer

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-03-01

Target Sample Size: Triple therapy group(ADT +Docetaxel + Darolutamide):111;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=276059

Disclaimer: Curate...